Induced abortion incidence and associated factors in a cohort of women living with HIV in Rio De Janeiro, Brazil, 1996–2016

2024-9-10

Prevalence of human immunodeficiency virus drug resistance and factors associated with high viral load among adolescents on antiretroviral therapy in Dar Es Salaam, Tanzania

2024-9-8

A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT

2024-9-8

Opportunities and challenges for the integration of managing non-communicable diseases within HIV care and treatment services in Tanzania

2024-9-5

Kaposi sarcoma and vertebral involvement in people with HIV: a case report and systematic literature review

2024-8-25

Factors driving decisions in the use of HIV pre-exposure prophylaxis: a real-world study in the United States

2024-8-8

Strengthening person-centered care through quality improvement: a mixed-methods study examining implementation of the Person-Centered Care Assessment Tool in Zambian health facilities

2024-7-22

The prevalence of vertical transmission of human immunodeficiency virus and associated factors among exposed infants in Eastern Lake zone and Southern Highland of Tanzania: a cross-sectional study

2024-7-16

Evaluating knowledge, practice, and attitude of Syrian population on sexually transmitted infections and human immunodeficiency virus

2024-7-13

‘The tablets make a certain noise’: uncovering barriers and enablers related to providing PMTCT services to adolescents and young women living with HIV in Zimbabwe

2024-6-30

Psychosocial and socioeconomic changes among low-income people with HIV during the COVID-19 pandemic in Miami-Dade County, Florida: racial/ethnic and gender differences

2024-6-21

Comorbidity and polypharmacy among people with HIV stratified by age, sex, and race

2024-5-30

General and healthcare-related HIV stigma among cisgender Brazilian women: the role of socioeconomic vulnerability

2024-5-27

Beyond community engagement: perspectives on the meaningful involvement of people with HIV and affected communities (MIPA) in HIV cure research in The Netherlands

2024-4-5

Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study

2022-9-6

Higher religiosity and spirituality are associated with ethnic group membership among middle-aged and older adults living with HIV

2022-8-24

Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions

2022-8-13

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D ² EFT

2022-8-8

Community HIV clinicians’ perceptions about HIV cure-related research in the Northwestern United States

2022-7-29

Digital directly observed therapy to monitor adherence to medications: a scoping review

2022-7-29

Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting

2022-6-27

Early infant diagnosis of HIV infection at the John F. Kennedy Medical Center, Monrovia, Liberia

2022-6-15

Impact of supervised aerobic exercise on clinical physiological and mental parameters of people living with HIV: a systematic review and meta-analyses of randomized controlled trials

2022-3-30

“We are looking at the future right now”: community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States

2022-3-29

Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants

2022-3-14

Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

2022-3-2

Does antiretroviral therapy change the relationship between body composition and muscle strength in children and adolescents diagnosed with HIV?

2022-2-22

Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies

2021-12-16

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial

2021-11-2

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

2021-11-2

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial.

2021-10-26

A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients.

2021-9-22

Effects of exercise training on bone mineral density in adults living with HIV: a retrospective study

2021-9-3

Effects of resistance training on muscle strength, body composition and immune-inflammatory markers in people living with HIV: a systematic review and Meta-analysis of randomized controlled trials

2021-9-3

A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients

2021-9-3

HIV and COVID-19: review of clinical course and outcomes

2021-7-4

Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil

2021-7-4

Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study

2021-7-4

Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium

2021-5-4

Expression of microRNA-155 in circulating T cells is an indicator of immune activation levels in HIV-1 infected patients

2021-5-4

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

2021-5-4

Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials

2021-3-4

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

2021-3-4

Impact of dedicated women’s outreach workers (WOWs) on recruitment of women in ACTG clinical studies

2021-3-4

Clinical and angiographical features of first episode of acute coronary syndrome in patients with human immunodeficiency virus infection

2021-1-2

Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research

2021-1-2

Developing a pilot lifestyle intervention to prevent cardiovascular disease in midlife women with HIV

2021-1-2

Changes in central adipose tissue after switching to integrase inhibitors

2020-11-1

Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1

2020-11-1

Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy

2020-11-1